Literature DB >> 19630792

Regulation of TFPI function by protein S.

T M Hackeng1, L F A Maurissen, E Castoldi, J Rosing.   

Abstract

Protein S is an anticoagulant cofactor of full-length tissue factor pathway inhibitor (TFPI) that facilitates optimal factor Xa-inhibition and efficient down-regulation of thrombin generation in plasma. Protein S and TFPI are constitutively active in plasma and therefore provide an effective anticoagulant barrier against unwanted procoagulant activity in the circulation. In this review, we describe the current status on how TFPI-activity depends on protein S, and show that TFPI and protein S are major regulators of thrombin generation both in the absence and presence of activated protein C (APC). As there is covariation of plasma TFPI and protein S levels both in health and in disease, these findings suggest that the risk of venous thrombosis associated with protein S deficiency states might be in part explained by the accompanying low plasma TFPI levels.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19630792     DOI: 10.1111/j.1538-7836.2009.03363.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  17 in total

Review 1.  New insights into modulation of thrombin formation.

Authors:  Henri M H Spronk; Julian I Borissoff; Hugo ten Cate
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

2.  The Journey of Protein S from an Anticoagulant to a Signaling Molecule.

Authors:  V S Pilli; William Plautz; Rinku Majumder
Journal:  JSM Biochem Mol Biol       Date:  2016-08-08

Review 3.  Protein C anticoagulant and cytoprotective pathways.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

Review 4.  Inherited risk factors for venous thromboembolism.

Authors:  Ida Martinelli; Valerio De Stefano; Pier M Mannucci
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

Review 5.  Progress in research into the genes associated with venous thromboembolism.

Authors:  Lian-Xing Zhao; Bo Liu; Chun-Sheng Li
Journal:  World J Emerg Med       Date:  2015

6.  Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus.

Authors:  Eric W Holroyd; Sinny Delacroix; Katarina Larsen; Adriana Harbuzariu; Peter J Psaltis; Ling Wang; Shuchong Pan; Thomas A White; Tyra A Witt; Laurel S Kleppe; Cheryl S Mueske; Debabrata Mukhopadhyay; Robert D Simari
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-01-05       Impact factor: 8.311

7.  Dependence on vitamin K-dependent protein S for eukaryotic cell secretion of the beta-chain of C4b-binding protein.

Authors:  Sofia Carlsson; Björn Dahlbäck
Journal:  J Biol Chem       Date:  2010-08-06       Impact factor: 5.157

8.  Protein S: a Multifunctional Anticoagulant.

Authors:  A'drianne Dorsey; Vijaya Satish Pilli; Howard Fried; Rinku Majumder
Journal:  Biomed Res Clin Pract       Date:  2017-11-20

9.  Molecular basis of the clotting defect in a bleeding patient missing the Asp-185 codon in the factor X gene.

Authors:  Qiuya Lu; Likui Yang; Chandrashekhara Manithody; Xuefeng Wang; Alireza R Rezaie
Journal:  Thromb Res       Date:  2014-08-20       Impact factor: 3.944

10.  Down-regulation of the clotting cascade by the protein C pathway.

Authors:  Fabian Stavenuiter; Eveline A M Bouwens; Laurent O Mosnier
Journal:  Hematol Educ       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.